Nintedanib

General Information

General Information
Nintedanib Impurities and Nintedanib

Daicel Pharma offers high-graded Nintedanib impurities such as (Z)-3-(1-hydroxypropylidene)-2-oxo-1-Propionlindoline-6-carboxylate, Acetyl impurity of Nintedanib CRS, Methyl Impurity of Nintedanib CRS, N-Acetyl Nintedanib Impurity, Nintedanib acid impurity, and more. These impurities are essential for evaluating Nintedanib quality, stability, and safety. Furthermore, Daicel Pharma provides a custom synthesis of Nintedanib impurities and distributes them internationally to fulfill the clientele’s needs.

Nintedanib [CAS: 656247-17-5] is a tyrosine kinase inhibitor treating Idiopathic Pulmonary Fibrosis (IPF) and chronic fibrosing interstitial lung diseases.

Nintedanib: Use and Commercial Availability  

Nintedanib treats idiopathic pulmonary fibrosis (IPF) and delays the decline of pulmonary function in individuals with systemic sclerosis-related interstitial lung disease. It treats progressive chronic fibrosing interstitial lung disorders. Nintedanib is available under the brand name Ofev.

The chemical name of Nintedanib is Methyl (Z)-3-[[[4-(N-methyl-2-(4-methylpiperazin-1-yl)acetamido)phenyl)amino)(phenyl)methylene)-2-oxoindoline-6-carboxylate. Its chemical formula is C₃₁H₃₃N₅O₄, and its molecular weight is approximately 539.6 g/mol.

Nintedanib inhibits multiple receptor tyrosine kinases (RTKs) such as platelet-derived growth factor receptor (PDGFR) α and β, vascular endothelial growth factor receptor (VEGFR) 1-3, fibroblast growth factor receptor (FGFR) 1-3, etc. It binds with the adenosine triphosphate (ATP) binding pocket of receptors and prevents the intracellular signaling for transformation, migrations, and proliferation of fibroblasts vital for IPF pathology.

Nintedanib Impurities and Synthesis

Nintedanib impurities refer to unwanted substances or by-products that may be present in the drug, Nintedanib. They can arise during the drug’s synthetic process¹, storage, or degradation. Controlling and monitoring impurities helps ensure Nintedanib quality, safety, and efficacy.

Daicel provides a Certificate of Analysis (CoA) of Nintedanib impurity standards like (Z)-3-(1-hydroxypropylidene)-2-oxo-1-Propionlindoline-6-carboxylate, Acetyl impurity of Nintedanib CRS, Methyl Impurity of Nintedanib CRS, N-Acetyl Nintedanib Impurity, Nintedanib acid impurity, and more. The CoA is generated from a cGMP-compliant analytical facility and includes comprehensive characterization data, such as 1H NMR, 13C NMR, IR, MASS, and HPLC purity. If requested, we give additional characterization data, such as 13C-DEPT. Daicel Pharma can synthesize unknown Nintedanib impurities or degradation products and supply labeled compounds to evaluate the effectiveness of generic Nilotinib. Each delivery comes with a complete characterization report. Daicel Pharma offers Nintedanib-D3, deuterium-labeled Nintedanib standards for bioanalytical research and BA/BE tests.